Biggest gainers and losers for June 15-19, 2026

AI Briefing

• – Biogen Inc. gained 12.5% after announcing positive Phase III trial results for its multiple sclerosis treatment.
• – Regeneron Pharmaceuticals lost 8.5% due to concerns over increased competition from generic versions.
• – Amgen Inc. rose 9.2% following a strong quarterly earnings report.